FDA On Clinical Trial Registries: Steer Clear Of Claims
This article was originally published in The Pink Sheet Daily
Executive Summary
Conclusions drawn from clinical trial registry postings could be construed as promotional claims, FDA ad division Director Abrams says. The agency will examine the "context and content" of a posting to determine whether it is promotional.